Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9


Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy.

Park J, Wrzesinski SH, Stern E, Look M, Criscione J, Ragheb R, Jay SM, Demento SL, Agawu A, Licona Limon P, Ferrandino AF, Gonzalez D, Habermann A, Flavell RA, Fahmy TM.

Nat Mater. 2012 Oct;11(10):895-905. doi: 10.1038/nmat3355. Epub 2012 Jul 15.


Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype.

Demento SL, Cui W, Criscione JM, Stern E, Tulipan J, Kaech SM, Fahmy TM.

Biomaterials. 2012 Jun;33(19):4957-64. doi: 10.1016/j.biomaterials.2012.03.041. Epub 2012 Apr 6.


Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccines.

Demento SL, Siefert AL, Bandyopadhyay A, Sharp FA, Fahmy TM.

Trends Biotechnol. 2011 Jun;29(6):294-306. doi: 10.1016/j.tibtech.2011.02.004. Epub 2011 Apr 2. Review.


The impact of nanoparticle ligand density on dendritic-cell targeted vaccines.

Bandyopadhyay A, Fine RL, Demento S, Bockenstedt LK, Fahmy TM.

Biomaterials. 2011 Apr;32(11):3094-105. doi: 10.1016/j.biomaterials.2010.12.054. Epub 2011 Jan 22.


TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis.

Demento SL, Bonafé N, Cui W, Kaech SM, Caplan MJ, Fikrig E, Ledizet M, Fahmy TM.

J Immunol. 2010 Sep 1;185(5):2989-97. doi: 10.4049/jimmunol.1000768. Epub 2010 Jul 26.


Spatiotemporal control over molecular delivery and cellular encapsulation from electropolymerized micro- and nanopatterned surfaces.

Stern E, Jay SM, Demento SL, Murelli RP, Reed MA, Malinski T, Spiegel DA, Mooney DJ, Fahmy TM.

Adv Funct Mater. 2009 Jul 13;19(18):2888-2895.


Biomimetic approaches to modulating the T cell immune response with nano- and micro- particles.

Demento S, Steenblock ER, Fahmy TM.

Conf Proc IEEE Eng Med Biol Soc. 2009;2009:1161-6. doi: 10.1109/IEMBS.2009.5332625.


Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy.

Demento SL, Eisenbarth SC, Foellmer HG, Platt C, Caplan MJ, Mark Saltzman W, Mellman I, Ledizet M, Fikrig E, Flavell RA, Fahmy TM.

Vaccine. 2009 May 18;27(23):3013-21. doi: 10.1016/j.vaccine.2009.03.034. Epub 2009 Apr 3.


Design opportunities for actively targeted nanoparticle vaccines.

Fahmy TM, Demento SL, Caplan MJ, Mellman I, Saltzman WM.

Nanomedicine (Lond). 2008 Jun;3(3):343-55. doi: 10.2217/17435889.3.3.343. Review.

Supplemental Content

Loading ...
Support Center